Home » Topics » Conferences

Conferences
RSS

Trimidox enhances effects of doxorubicin in vivo

May 13, 1997

Dual 5alpha-reductase type I/II inhibitor from Lilly for prostatic cancer

May 12, 1997

Lilly prepares raloxifene analogs that reverse MRP-mediated resistance

May 12, 1997

Retinoid-like compounds that induce apoptosis in cancer cells

May 12, 1997

Glycan-conjugated 5-FU for the treatment of hepatocellular cancer/metastases

May 12, 1997

Taiho discovers potent and selective cdc25PTP inhibitors

May 12, 1997

Parke-Davis develops new c-src TK inhibitors

May 12, 1997

RPR selects farnesyltransferase inhibitor for in vivo evaluation

May 12, 1997

Schering-Plough evaluates novel farnesyltransferase inhibitor

May 12, 1997

TAS-103 shows antitumor activity against orthotopically implanted human cancers

May 12, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 30, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...